{
  "zolgensma": {
    "condition": "spinal muscular atrophy",
    "approval_status": "FDA approved",
    "type": "AAV gene therapy (in vivo)",
    "developer": "Novartis"
  },
  "luxturna": {
    "condition": "RPE65 mutation retinal dystrophy",
    "approval_status": "FDA approved",
    "type": "AAV gene therapy (in vivo)",
    "developer": "Spark Therapeutics"
  },
  "elevidys": {
    "condition": "duchenne muscular dystrophy",
    "approval_status": "FDA approved",
    "type": "AAV gene therapy (in vivo)",
    "developer": "Sarepta Therapeutics"
  },
  "roctavian": {
    "condition": "hemophilia A",
    "approval_status": "FDA approved",
    "type": "AAV gene therapy (in vivo)",
    "developer": "BioMarin"
  }
}
